top of page
Abstract Black Wave
About
Leadership
Our Team
> View Bio
HS Ring.png
Robert H. Ring
Chief Executive Officer
View Bio
  • linkedin icon
> View Bio
HS (Team) - Valentin Gribkoff.png
Valentin Gribkoff
Ion Channel Pharmacology
View Bio
  • linkedin icon
> View Bio
HS Hoeben.jpg
Eef Hoeben
DMPK
View Bio
  • linkedin icon
> View Bio
HS (Team) - Desirée Kanters.png
Desirée Kanters 
Clinical Operations
View Bio
  • linkedin icon
> View Bio
HS Ceusters.png
Marc Ceusters
Head of Development
View Bio
  • linkedin icon
> View Bio
HS Peters.png
Annelieke Peters
Toxicology
View Bio
  • linkedin icon
> View Bio
HS Betsbrugge.jpg
Jo Van Betsbrugge
CMC
View Bio
  • linkedin icon
> View Bio
HS (Team) - Nicholas Stern (1).png
Nicholas Stern
Chief Financial Officer
View Bio
  • linkedin icon
Board of Directors
Board of Directors
> View Bio
HS (BoD) - Paul Sekhri.png
Paul Sekhri
View Bio
  • linkedin icon
> View Bio
HS De Rubertis.png
Francesco de Rubertis
View Bio
  • linkedin icon
> View Bio
HS Ollier.jpg
Michèle Ollier
View Bio
  • linkedin icon
> View Bio
HS (BoD) - Howard Mayer.png
Howard Mayer
View Bio
  • linkedin icon
Advisors
Advisors
Untitled.jpg
Roy Twyman
View Bio
  • linkedin icon
HS (Team) - Joe Horrigan.png
Joseph Horrigan
View Bio
  • linkedin icon
HS Pandina.jpg
Gahan Pandina
  • linkedin icon
HS Garafalo.png
Elizabeth Garafalo
  • linkedin icon
HS Hagerman.jpg
Randi Hagerman
  • linkedin icon
HS (SAB) - Olivier Perche.png
Olivier Perche
  • linkedin icon
1884612574 (Lab Scene 2 scientists by microscope)_edited.jpg
Reach out to learn more
Connect with Kaerus to learn more about our company’s targeted therapeutics programs for Fragile X Syndrome and other rare neurodevelopmental disorders. 
bottom of page